MedDRA Electronic Adverse Event Reporting Produces Rise In Case Reports
This article was originally published in The Pink Sheet Daily
Executive Summary
The number of electronic reports submitted by the 13 companies using MedDRA has roughly doubled since May, CDER Senior Program Manager Andrea Feight says. FDA is working with other regulatory agencies to expand MedDRA terminology.
You may also be interested in...
FDA Begins Publishing Raw Adverse Event Data From AERS
The agency's website includes quarterly data from its Adverse Events Reporting System. FDA's goal is to publish the AERS data within two weeks after the quarter's end.
FDA Begins Publishing Raw Adverse Event Data From AERS
The agency's website includes quarterly data from its Adverse Events Reporting System. FDA's goal is to publish the AERS data within two weeks after the quarter's end.
Limitations Of FDA's Adverse Event Reporting System Highlighted By Vioxx
Merck's withdrawal of Vioxx illustrates the shortcomings of adverse event reporting systems for detecting common events